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Experimental autoimmune encephalomyelitis (EAE) in rodents is frequently used as an 
animal model for multiple sclerosis (MS). A potential role of individual genes in MS 
pathogenesis is regularly investigated by comparing EAE development in gene-targeted mice 
with that in their wild-type littermates [1]. Clinical disease in EAE models ultimately amounts 
to motor dysfunction, thus EAE severity is generally scored in correlation to the severity of 
paralysis. However, there is no international standard scoring system, which research groups 
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would use to measure EAE severity and clinical assessment scales mostly in use reach from 
0-3 points to 0-6 points [2-5]. The use of different EAE scoring systems prohibits direct 
comparison of clinical EAE data published from different laboratories. Different scoring 
might include differences in the subjective bias influencing the scoring and might also lead to 
differences in the results reported from the different laboratories, including differences in 
the statistical significance reported. Refined clinical EAE scoring includes sophisticated motor 
skill testing, which increases mouse handling time causing increased distress for the animals. 
Considering the 3R rules, aiming to refine animal experiments, we here asked if extended 
scoring of EAE in mice will grant improved documentation of clinical EAE allowing to perform 
a more powerful statistical analysis and thus identify more subtle differences when 
comparing EAE courses in different groups of mice.  To this end we compared EAE scores in 
wild-type SJL/J and C57BL/6J mice with different knockout littermates, respectively using a 0-
3 point scale used in our laboratory [6, 7] (Materials and Methods in Supporting Information) 
and a second, more refined scoring system [8, 9], which includes sophisticated evaluation of 
motor skill testing such as grid walk, a righting test (the ability of mice to turn over when 
they have been placed on their back) and a hanging test to determine front limb weakness. 
The latter score also included unilateral disease signs, which were scored as intermediate 
steps of 0.5 (Material and Methods). Over a time period of 9 months, 6 different researchers 
evaluated the disease progression in actively induced EAE (aEAE) models in both, C57BL/6J 
and SJL/J mice as described before [7] as well as in an adoptive transfer EAE (tEAE) model 
induced by the transfer of 2D2 T cells into C57BL/6 mice [10] in comparison to their 
respective knockout littermates using the two scoring systems in parallel. During the time of 
observation a total of 10 different mouse strains (C57BL/6 and SJL/J 2 wild-type mouse lines 
and 8 knockout mouse lines) were analyzed in 3 independent tEAE (n = 46) and 5 
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independent aEAE experiments (n = 157) and were included into the study. Graphical display 
of the disease course of not significantly different aEAE experiments (Fig. 1A), significantly 
different aEAE experiments (Fig. 1 E), and the tEAE experiments (Fig. 1I) evaluated with a 3-
point scale showed a slightly less soft curve when compared to the curve revealed by the 
5.5-point scale (Fig. 1C, G, K). The area under the curve (AUC) of the overall disease severity 
(Fig. 1B, D, F, H, J, L) was calculated for each mouse for the 3-point and the 5.5-point scale to 
compare the disease course of wild-type and knockout mice using non-parametric statistical 
tests (Mann Whitney test, also referred to as Wilcoxon rank-sum test). Despite a clear visual 
difference of the graphs with the 5.5-point scale and the graph with the 3-point scale, the 
obtained p-values were hardly different or even identical. Thus, we next asked whether the 
two scoring systems are really providing fundamentally different information. To address 
this we compared the discrepancies of the two scoring measurement methods by 
constructing Bland-Altman plots [11]. In these plots, the means of the two measurement 
systems on the same observation (on x-axis) are plotted against the differences of the two 
measurements (on y-axis). For these plots we rescaled the scorings from the 5.5-point scale 
to have a maximum of 3 (as the 3-point scale scorings) and similarly the corresponding area 
under the curve values (Figure 2 A-C). Additionally we constructed Bland-Altman plots for 
the relative ranks of the AUC derived from the 3-point and 5.5-point scorings (Fig. 2 D-F) for 
all three experiments. We found that there was a high agreement between the two 
measurement methods, suggesting that the amount of information of the two scoring 
systems is comparable, especially the relative rankings were very similar which then, in turn, 
resulted in very similar p-values when comparing wild-type with knockout mice with non-
parametric statistical tests. Finally, statistical analysis of additional parameters e.g. mean day 
of onset, mean maximal disease score and mean day of resolution using the two different 
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scorings also produced similar or identical p-values (Supporting Information Fig. 1).  Taken 
together, our results show that although a refined EAE scoring improves graphic 
representation of different clinical EAE scores between two groups, it failed to relevantly 
improve the ability to statistically establish differences between the overall disease course of 
the two groups of mice. Based on these observations we propose that 3-point scoring of 
disease progression in EAE is preferable to refined scoring systems as it comes, for almost 
the same amount of information, with less distress for the assessed mice and is thus more in 
line with the 3R guidelines.  
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Figure legends 
 
Figure 1. Comparison of two different EAE scoring protocols to assess the severity of EAE.  
(A-H) Active EAE (aEAE) was induced in (A-D) wild-type SJL/J mice and knockout (KO) 
littermates  and (E-H) in wild-type C57BL/6 mice and KO littermates as described [7]. (I-K) 
Adoptive transfer EAE (tEAE) using 2D2 TCR transgenic CD4+ T cells was induced as described 
[10]. Representative disease courses of both aEAE and tEAE are shown. (A, C) The disease 
course of EAE was evaluated with (A) a 3-point scale and (C) a 5.5-point scale as well as (E, G) 
the disease course of a significantly different aEAE was evaluated with (E) a 3-point scale and 
(G) a 5.5-point scale, and (I, K) the disease course the tEAE was evaluated with (I) a 3-point 
scale and a (K) 5.5-point scale, and. (B, D, F, H, J, L) The severity of the disease was analyzed 
by the evaluation of the area under the curve (AUC). (A-D) Fifteen mice per group, data 
shown are from a single experiment representative of five independent experiments 
including a total of 157 mice. (E-H) Twelve C57BL/6 mice and six KO mice, data shown are 
from a single experiment representative of five independent experiments including a total of 
157 mice. (I-K) Six mice per group, data shown are from a single experiment representative 
of three independent experiments including a total of 46 mice. (B, D, F, H, J, L) p values of 
the AUC were determined by Mann-Whitney test using GraphPad Prism 6 software. Data are 
shown as means ± SD. 
 
Figure 2. Bland-Altman plots of AUC values and of ranks of the AUC from the two scoring 
systems 
Bland-Altman plots of the AUC derived from 3-point and rescaled 5.5-point scoring for active 
EAE induced in wild-type (WT) and knockout (KO) mice with (A) non-significant difference in 
disease severity and (B) significant difference in disease severity, and (C) with non-significant 
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difference in disease severity between tEAE in wild-type (WT) and knockout mice. (D to F) 
Bland-Altman plots for the ranks of the AUC derived from the 3-point and rescaled 5.5-point 
scoring for the same experiments as shown in (A to C) are shown. In Bland-Altman plots the 
means of the two measurement systems on the same observation (on x-axis) are plotted 
against the differences of the two measurements (on y-axis). The grey shaded area gives the 
95% range for the difference between the two measurement systems. 
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Figure 2 
 
